Trademark: 76306207
Word
OXIGENE THE VASCULAR TARGETING COMPANY
Status Date
Friday, May 13, 2011
Registration Number
2893720
Registration Date
Tuesday, October 12, 2004
Filing Date
Tuesday, August 28, 2001
Published for Opposition
Tuesday, April 22, 2003
Cancellation Date
Friday, May 13, 2011
42 Cancer research; research and development of biopharmaceutical products, namely, vascular targeting agents and cancer therapies; and licensing of intellectual property in the field of biopharmaceutical compounds for vascular targeting agents and cancer therapies
"THE VASCULAR TARGETING COMPANY"
May 13, 2011
Cancelled Sec. 8 (6-Yr)
Oct 12, 2004
Registered-Principal Register
Aug 16, 2004
Law Office Registration Review Completed
Aug 3, 2004
Assigned To Lie
Jul 28, 2004
Allowed Principal Register - Sou Accepted
Jul 28, 2004
Assigned To Examiner
Jul 26, 2004
Statement Of Use Processing Complete
Jan 15, 2004
Use Amendment Filed
Jul 26, 2004
Extension 1 Granted
Jan 13, 2004
Extension 1 Filed
May 24, 2004
Case File In Ticrs
Jan 15, 2004
Paper Received
Jan 13, 2004
Fax Received
Jul 15, 2003
Noa Mailed - Sou Required From Applicant
Apr 22, 2003
Published For Opposition
Apr 2, 2003
Notice Of Publication
Dec 12, 2002
Approved For Pub - Principal Register
Dec 6, 2002
Correspondence Received In Law Office
Jun 10, 2002
Final Refusal Mailed
Apr 30, 2002
Correspondence Received In Law Office
Apr 30, 2002
Paper Received
Nov 2, 2001
Non-Final Action Mailed
Oct 12, 2001
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
